BLISSGVS News Today

Bliss GVS Pharma Ltd Share Price

BLISSGVS

CMP as on 01-Dec-23 12:00
₹ 141

icon 0.35 | 0.25%

Open
₹ 142
Turnover(lac)
₹ 399
Prev. Close
₹ 140.80
Day's Vol (shares)
₹ 282,923
Day's Vol (shares)
₹ 140.45         ₹ 143.20

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
Image not found

Banks recalled their loans when PCJ disclosed in an October 2018 stock exchange statement that it had defaulted on Rs 3,466 crore in this regard. SBI then filed a complaint with the Debt Recovery Appellate Tribunal.

  • 30 November, 2023
  • 12:22 PM
  • less than a minute
Image not found

The approved product is therapeutically equivalent to the reference listed drug, Prezista tablets by Janssen products.

  • 29 November, 2023
  • 1:52 PM
  • less than a minute
Blog Image

Alpha GCC Holdings Ltd, a wholly-owned material subsidiary of Aster DM Healthcare, manages Aster's operations in the GCC (Gulf Cooperation Council) countries.

  • 29 November, 2023
  • 9:20 AM
  • less than a minute
Image not found

The inspection, conducted between August 23 and 26, focused on pre-market aspects and US FDA's quality system, particularly the current good manufacturing practice regulations for medical devices

  • 24 November, 2023
  • 2:14 PM
  • less than a minute
Image not found

This marks the 31st consecutive year that NTPC Ltd has distributed dividends

  • 24 November, 2023
  • 8:02 AM
  • less than a minute
Blog Image

Flair Pens is a household brand in India and the company’s IPO is set to open tomorrow. Sheetal Agarwal of IIFL recently caught up with the management.

  • 21 November, 2023
  • 10:43 AM
  • less than a minute
Image not found

The involved parties include Exide Industries Ltd, Vertiv Company Group Ltd UK, and Vertiv Energy Pvt Ltd India

  • 20 November, 2023
  • 2:32 PM
  • less than a minute
Blog Image

The inspection took place from November 13 to 17 and ended with zero observations.

  • 20 November, 2023
  • 11:12 AM
  • less than a minute
Blog Image

The strategic move aligns with AstraZeneca's commitment to advancing access to innovative medicines in India and leading in specialist disease areas.

  • 17 November, 2023
  • 12:10 PM
  • less than a minute
Blog Image

Dabur International Ltd and Dermoviva Skin Essentials Inc were discharged as defendants in federal litigation in the United States.

  • 16 November, 2023
  • 12:30 PM
  • less than a minute